Hospitals will be in danger of drug shortages in the event of a no-deal Brexit, NHS trusts have warned privately.
Poorly coordinated ministers and health service bosses have failed to properly prepare for the possibility of the UK crashing out of the European Union, according to a leaked letter from NHS Providers, which represents the trusts.
“Public health and disease control coordination could suffer,” said the organisation’s chief executive Chris Hopson, who warned a hard Brexit or no deal could negatively impact upon “the entire supply chain of pharmaceuticals”.
No-deal Brexit ‘a mistake we’d regret for generations’, says Hunt
Brexit could also jeopardise the status of EU workers ”on which the NHS relies”, he added.
Mr Hopson’s letter was sent to NHS England chief executive Simon Stevens and NHS Improvement chief Ian Dalton on Friday, and copied to Brexit secretary Dominic Raab and officials at the Department for Health. It was later leaked to The Times.
The letter comes days after the British Medical Association (BMA) warned leaving the EU without a deal would leave Britain more vulnerable to outbreaks of deadly infectious diseases and increase the risk of a Europe-wide pandemic.
The possibility of a no-deal or hard Brexit “with minimal regulatory alignment appears to be growing”, warned Mr Hopson.
He wrote: “For as long as that risk remains, it is important that detailed operation planning is undertaken across the NHS. Yet trusts tell us that their work in this area is being hampered by the lack of visible and appropriate communication.
“Our members have begun planning... but they have hit a problem, in that some activities are clearly best done at a national level and, in the view of trusts, are best co-ordinated by NHS England and NHS Improvement.
www.independent.co.uk/news/health/no-deal-brexit-nhs-medicine-shortages-drugs-providers-chris-hopson-eu-a8500446.html